Imugene Announces Extraordinary General Meeting for 2025

Tip Ranks
2025.07.21 06:25
portai
I'm PortAI, I can summarize articles.

Imugene Limited has announced an Extraordinary General Meeting on August 20, 2025, to be held in Sydney and online via Zoom. This meeting allows shareholders to engage in strategic decisions and vote on key issues, emphasizing the company's commitment to transparent governance. The latest analyst rating for Imugene (AU:IMU) is a Buy with a price target of A$0.42. The company focuses on developing cancer immunotherapies and has a current market cap of A$82.4M, with a year-to-date price performance of -70.19%.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
  • Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.

Imugene ( (AU:IMU) ) has provided an update.

Imugene Limited has announced an Extraordinary General Meeting scheduled for August 20, 2025, to be held both in-person in Sydney and online via Zoom. This meeting is significant for shareholders as it provides an opportunity to engage in the company’s strategic decisions and vote on key issues, reflecting Imugene’s commitment to maintaining transparent and inclusive governance practices.

The most recent analyst rating on (AU:IMU) stock is a Buy with a A$0.42 price target. To see the full list of analyst forecasts on Imugene stock, see the AU:IMU Stock Forecast page.

More about Imugene

Imugene Limited is a biotechnology company focused on the development of novel therapies for cancer treatment. The company specializes in immuno-oncology, aiming to harness the immune system to fight cancer, and is actively involved in advancing its pipeline of cancer immunotherapies.

YTD Price Performance: -70.19%

Average Trading Volume: 617,700

Technical Sentiment Signal: Sell

Current Market Cap: A$82.4M

See more insights into IMU stock on TipRanks’ Stock Analysis page.

Trending Articles:

  • ‘Ultra Bullish,’ Says Top Investor About Alphabet Stock
  • ‘Stay Realistic,’ Says Piper Sandler About SoundHound AI Stock
  • ‘Don’t Pull the Trigger Just Yet,’ Says Top Investor About Nvidia Stock

Disclaimer & DisclosureReport an Issue

Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.